List of partners

The following companies and organisations have confirmed their participation in the 33rd ECNP Congress.

In alphabetical order: 

ANGELINI
Industry Satellite Symposium: ISS.09

Angelini Pharma is committed to give hope to patients in the areas of CNS (included pain), Rare Diseases and Consumer Health. Angelini Pharma has an extensive R&D programs, world-class manufacturing and marketing of both active ingredients and branded drugs.
www.angelinipharma.com

Angelini 
EUFAMI
Stand number: 11

EUFAMI is an international NGO based in Belgium committed to improving the care for and welfare of people with mental ill health. Our mission is to represent at the European level all family members of persons affected by mental ill health and to protect their rights and interests.
www.eufami.org

EUFAMI 
European Brain Council (EBC)
Stand number: 13

The European Brain Council is a network of key players in the “Brain Area”, with a membership encompassing scientific societies, patient organisations, professional societies and industry partners. Its main mission is to promote brain research with the ultimate goal of improving the lives of the estimated 179 million Europeans living with brain conditions.
www.braincouncil.eu

European Brain Council 

GAMIAN-Europe
Stand number: 12

Global Alliance of Mental Illness Advocacy Networks-Europe (GAMIAN-Europe) Is a patient-driven pan-European organisation, representing and advocating the interests and rights of persons affected by mental ill health. Its main activities relate to advocacy, information, awareness-raising and education and partnership and capacity building. Overarching themes in our work relate to anti-stigma and discrimination and patients’ rights.
www.gamian.eu

 GAMIAN-EUROPE

Gedeon Richter Plc & RECORDATI S.p.A
Stand number: 4
Industry Satellite Symposium: ISS.06


Headquartered in Hungary, Gedeon Richter is an innovation-driven specialty pharmaceutical company, boasting the biggest pharmaceutical research centre in CEU. Its latest achievement is the original antipsychotic compound, cariprazine, already marketed in the US for BD and schizophrenia treatment and in majority of the EU countries for the treatment of schizophrenia in adult patients.
www.richter.hu

Richter Gedeon

Recordati is an international pharmaceutical group, listed on the Italian Stock Exchange, dedicated to the research, development and marketing of pharmaceuticals products. Recordati is committed to the research and development of new specialties in cardiovascular, urological and psychiatric areas with a focus on treatments for rare diseases.
www.recordati.it


Recordati 

Global Medical Education/Takeda
Industry Satellite Symposium: ISS.01

Global Medical Education/Sunovion
Industry Satellite Symposium: ISS.03

GME
Global Medical Education is one of the leading providers of CME in Psychiatry in the USA. It organizes live meetings, satellite symposia, webcasts and enduring content. GME has partnered with the ECNP for the last 4 years to do satellite symposia and science exchange sessions.
www.gmeded.com

 

H. Lundbeck A/S
Industry Satellite Symposium: ISS.05

Lundbeck is a global pharmaceutical company specialized in discovering and developing innovative treatments for brain diseases. At Lundbeck, we are tirelessly dedicated to restoring brain health, so every person can be their best.
www.lundbeck.com #brainhealth #progressinmind

Lundbeck 
JAMA Network
Stand number: 16

JAMA, JAMA Network Open, JAMA Health Forum, and the specialty journals in the JAMA Network provide health care professionals around the world with trusted original research, opinion, education, and multimedia of the highest quality and integrity. Read, view, listen, and learn at jamanetwork.com.
www.jamanetwork.com

JAMA Network
Janssen Pharmaceutica NV
Stand number: 6 and 7
Industry Satellite Symposium: ISS.04 and ISS.07

At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension.
www.janssen.com/emea
Follow us at www.twitter.com/JanssenEMEA.
Janssen Pharmaceutica NV is one of the Janssen Pharmaceutical Companies of Johnson & Johnson

Janssen Pharmaceutica NV
Medscape Psychiatry
(unrestricted educational grant from Lundbeck A/S)
Industry Satellite Symposium: ISS.02

Medscape is a website providing access to medical information for clinicians; the organization also provides continuing education for physicians and health professionals.
www.medscape.org/psychiatry

Medscape educational global 
SERVIER
Stand number: 8
Industry Science Exchange: ISE.02


Servier is an international independent pharmaceutical company governed by a non-profit foundation. Servier, in constant search for innovation, has a heavy investment in neuropharmacology for the treatment of brain diseases, mainly focused in depression- agomelatine is approved since 2009 for the treatment of major depressive episodes- and autism spectrum disorders.
www.servier.com

SERVIER 
Sunovion Pharmaceuticals Europe Ltd
Stand number: 5
Industry Satellite Symposium: ISS.09


At Sunovion Pharmaceuticals Europe Ltd., we focus on the introduction and commercialisation of innovative medicines, with a current specialisation in mental health. Sunovion Pharmaceuticals Europe, headquartered in London, is a wholly owned subsidiary of Sunovion Pharmaceuticals Inc.
Sunovion Pharmaceuticals Inc., an indirect, wholly owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd., is headquartered in Marlborough, Massachusetts, US.
www.sunovion.eu

Sunovion 
Sunovion, Sumitomo Dainippon, Angelini
Industry Satellite Symposium: ISS.09

Sumitomo Dainippon Pharma is among the top-ten listed pharmaceutical companies in Japan, operating globally in major pharmaceutical markets, including Japan, the U.S., China and the European Union. Sumitomo Dainippon Pharma aims to create innovative pharmaceutical products in the Psychiatry & Neurology area, the Oncology area and Regenerative medicine/Cell therapy field, which have been designated as the focus therapeutic areas. Today Sumitomo Dainippon Pharma has more than 6,000 employees worldwide.
www.ds-pharma.com

Sunovion, Sumitomo Dainippon, Angelini 
Upjohn, A Pfizer Division
Industry Science Exchange: ISE.01

At Upjohn, our mission is relieving the burden of NCDs with trusted, quality medicines for every patient, everywhere.
https://www.pfizer.com/products/upjohn
 
Upjohn-Pfizer